EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances in leflunomide therapy: mechanistic insights, clinical uses, and drug delivery approaches

Pratham Khandelwal, Saumyadeep Bora, Raju Vidap, Hitesh Kulhari, Deep Pooja

Frontiers in Pharmacology · 10.11.2026 · 17

DOI: 10.3389/fphar.2026.1962870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.11.2026. Verfasst von Pratham Khandelwal und 4 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leflunomide (LEF) is a disease-modifying antirheumatic drug that primarily inhibits dihydroorotate dehydrogenase, thereby suppressing de novo pyrimidine synthesis and limiting activated lymphocyte proliferation. Beyond rheumatoid arthritis, its therapeutic potential has been explored in other inflammatory and autoimmune conditions. However, oral use is constrained by limited solubility, variable bioavailability, and systemic adverse effects. To address these limitations, diverse drug delivery platforms, including lipid-based systems, polymeric carriers, hydrogels, implants, and nanostructured formulations, have been investigated to improve localization, sustain release, and enhance therapeutic efficiency. These approaches aim to reduce toxicity while improving pharmacokinetic behaviour and patient outcomes. This review highlights how formulation design may expand the clinical utility of LEF and support more precise and safer treatment strategies for chronic inflammatory diseases.

Zitieren

APA

Khandelwal, P., Bora, S., Vidap, R., Kulhari, H., & Pooja, D. (2026). Advances in leflunomide therapy: mechanistic insights, clinical uses, and drug delivery approaches. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1962870

Vancouver

Khandelwal P, Bora S, Vidap R, Kulhari H, Pooja D. Advances in leflunomide therapy: mechanistic insights, clinical uses, and drug delivery approaches. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1962870

BibTeX
@article{Khandelwal2026,
  author = {Khandelwal, Pratham and Bora, Saumyadeep and Vidap, Raju and Kulhari, Hitesh and Pooja, Deep},
  title = {Advances in leflunomide therapy: mechanistic insights, clinical uses, and drug delivery approaches},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1962870}
}
Kostenlos starten →